MENU
+Compare
ERFSF
Stock ticker: OTC
AS OF
Nov 12 closing price
Price
$67.39
Change
-$3.24 (-4.59%)
Capitalization
12.02B

ERFSF Eurofins Scientific Nante Forecast, Technical & Fundamental Analysis

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services... Show more

ERFSF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ERFSF with price predictions
Nov 12, 2025

Momentum Indicator for ERFSF turns negative, indicating new downward trend

ERFSF saw its Momentum Indicator move below the 0 level on October 27, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 135 similar instances where the indicator turned negative. In of the 135 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ERFSF turned negative on November 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 58 similar instances when the indicator turned negative. In of the 58 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ERFSF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ERFSF entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where ERFSF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ERFSF advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

ERFSF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.223) is normal, around the industry mean (12.372). P/E Ratio (25.688) is within average values for comparable stocks, (132.213). Projected Growth (PEG Ratio) (0.705) is also within normal values, averaging (1.928). Dividend Yield (0.010) settles around the average of (0.017) among similar stocks. P/S Ratio (1.556) is also within normal values, averaging (9.791).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ERFSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ERFSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ERFSF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

ERFSF paid dividends on July 05, 2021

Eurofins Scientific Nante ERFSF Stock Dividends
А dividend of $0.68 per share was paid with a record date of July 05, 2021, and an ex-dividend date of July 01, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
23 Val Fleuri
Phone
+352 26185321
Employees
62000
Web
https://www.eurofins.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FGDL56.061.06
+1.93%
Franklin Responsibly Sourced Gold ETF
IWX90.540.45
+0.50%
iShares Russell Top 200 Value ETF
FBUF30.650.02
+0.07%
Fidelity Dynamic Buffered Equity ETF
UPGD74.03N/A
N/A
Invesco Bloomberg Analyst Rating Imp ETF
SMAX27.01-0.01
-0.04%
iShares Large Cap Max Buffer Sep ETF

ERFSF and Stocks

Correlation & Price change

A.I.dvisor tells us that ERFSF and RGEN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERFSF and RGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERFSF
1D Price
Change %
ERFSF100%
-4.59%
RGEN - ERFSF
26%
Poorly correlated
+2.98%
KIDS - ERFSF
22%
Poorly correlated
-1.28%
SAUHY - ERFSF
22%
Poorly correlated
+0.93%
BFLY - ERFSF
22%
Poorly correlated
-8.13%
SOAGY - ERFSF
22%
Poorly correlated
-0.07%
More